Literature DB >> 11917227

Immunohistochemical analysis of alphavbeta5 and alphavbeta6 integrins in the endometrium and endometriosis.

Libertad A Puy1, Carol Pang, Clifford L Librach.   

Abstract

We performed a case-controlled study to study the immunoreactivity patterns and staining intensity of alphavbeta5 and alphavbeta6 integrins in ectopic and eutopic endometrium from women with endometriosis and compared them with those in normal control endometrium. Forty eutopic and ectopic samples from patients with endometriosis were compared with 12 control endometrial samples. Staining was evaluated using a computerized image analysis system by a blinded, independent observer. The immunoreactivity patterns for both alphavbeta5 and alphavbeta6 were very similar. In eutopic endometrium from women with or without endometriosis, the immunostaining intensity score for both integrins was stronger during the secretory than the proliferative phase. Immunoreactivity in endometriosis was greater than in eutopic endometrium. There were no significant menstrual cycle-related staining differences in endometriosis. The percentage of blood vessels immunolabeled was greater in endometriosis than eutopic endometrium from endometriosis patients and greater in eutopic endometrium from these patients compared with control endometrium. Ectopic tissue from patients with stages I and II endometriosis showed significantly higher staining intensity than ectopic tissue from patients with stages III and IV disease. Determination of the specific functional consequences of the differences observed in alphavbeta5 and alphavbeta6 integrin immunostaining may provide an increased understanding regarding the pathogenesis of endometriosis.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11917227     DOI: 10.1097/00004347-200204000-00010

Source DB:  PubMed          Journal:  Int J Gynecol Pathol        ISSN: 0277-1691            Impact factor:   2.762


  5 in total

1.  A conditionally replicative adenovirus, CRAd-S-pK7, can target endometriosis with a cell-killing effect.

Authors:  A A V Paupoo; Z B Zhu; M Wang; D T Rein; A Starzinski-Powitz; D T Curiel
Journal:  Hum Reprod       Date:  2010-06-23       Impact factor: 6.918

2.  Toward gene therapy of endometriosis: transductional and transcriptional targeting of adenoviral vectors to endometriosis cells.

Authors:  Essam-Eldin R Othman; Zeng B Zhu; David T Curiel; Nilufar Khatoon; Hosam T Salem; Essam Al-Din M Khalifa; Ayman Al-Hendy
Journal:  Am J Obstet Gynecol       Date:  2008-08       Impact factor: 8.661

Review 3.  Endometrial biomarkers for the non-invasive diagnosis of endometriosis.

Authors:  Devashana Gupta; M Louise Hull; Ian Fraser; Laura Miller; Patrick M M Bossuyt; Neil Johnson; Vicki Nisenblat
Journal:  Cochrane Database Syst Rev       Date:  2016-04-20

4.  Targeting Anthrax Toxin Receptor 2 Ameliorates Endometriosis Progression.

Authors:  Shih-Chieh Lin; Hsiu-Chi Lee; Ching-Ting Hsu; Yi-Han Huang; Wan-Ning Li; Pei-Ling Hsu; Meng-Hsing Wu; Shaw-Jenq Tsai
Journal:  Theranostics       Date:  2019-01-21       Impact factor: 11.556

5.  Transforming growth factor β1 enhances adhesion of endometrial cells to mesothelium by regulating integrin expression.

Authors:  Hee-Jung Choi; Mi-Ju Park; Bo-Sung Kim; Hee-Jin Choi; Bosun Joo; Kyu Sup Lee; Jung-Hye Choi; Tae-Wook Chung; Ki-Tae Ha
Journal:  BMB Rep       Date:  2017-08       Impact factor: 4.778

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.